User profiles for "author:Samantha Baillie"
 | Samantha BaillieSt George's University Hospital Verified email at nhs.net Cited by 130 |
Systematic review with meta‐analysis: time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease
N Jayasooriya, S Baillie, J Blackwell… - Alimentary …, 2023 - Wiley Online Library
Background The impact of diagnostic delay on the clinical course of inflammatory bowel
disease (IBD) remains uncertain. Aim To perform a systematic review of time to diagnosis …
disease (IBD) remains uncertain. Aim To perform a systematic review of time to diagnosis …
Systematic review with meta‐analysis: effectiveness of anti‐inflammatory therapy in immune checkpoint inhibitor‐induced enterocolitis
Background Immune checkpoint inhibitors have revolutionised cancer treatment, but at the
cost of off‐target immune‐mediated organ damage. This includes checkpoint inhibitor …
cost of off‐target immune‐mediated organ damage. This includes checkpoint inhibitor …
[HTML][HTML] Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre …
S Sebastian, GJ Walker, NA Kennedy… - The Lancet …, 2021 - thelancet.com
Background There is a paucity of evidence to support safe and effective management of
patients with acute severe ulcerative colitis during the COVID-19 pandemic. We sought to …
patients with acute severe ulcerative colitis during the COVID-19 pandemic. We sought to …
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
S Honap, L Al-Hillawi, S Baillie, A Bancil… - Frontline …, 2022 - fg.bmj.com
Objective Ustekinumab is an interleukin-12/interleukin-23 receptor antagonist licensed for
the treatment of ulcerative colitis (UC). Clinical trial data were promising; however, real …
the treatment of ulcerative colitis (UC). Clinical trial data were promising; however, real …
Chronic abdominal pain in inflammatory bowel disease: a practical guide
Pain is common in inflammatory bowel disease (IBD), yet many patients feel their pain is not
addressed by healthcare professionals. Listening to a patient's concerns about pain …
addressed by healthcare professionals. Listening to a patient's concerns about pain …
Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project
S Baillie, JK Limdi, A Bassi, A Fraser, G Parkes… - Frontline …, 2023 - fg.bmj.com
Objective Despite its association with poorer outcomes, opioid use in inflammatory bowel
disease (IBD) is not well characterised in the UK. We aimed to examine the extent of opioid …
disease (IBD) is not well characterised in the UK. We aimed to examine the extent of opioid …
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD …
A Saifuddin, AJ Kent, SJ Mehta… - Alimentary …, 2022 - Wiley Online Library
Background The COVID‐19 pandemic offered a unique opportunity to understand
inflammatory bowel disease (IBD) management during unexpected disruption. This could …
inflammatory bowel disease (IBD) management during unexpected disruption. This could …
[HTML][HTML] Using clinical cases to guide healthcare
Evidence-based practice (EBP) has been the gold standard in healthcare for nearly three
centuries and aims to assist physicians in providing the safest and most effective healthcare …
centuries and aims to assist physicians in providing the safest and most effective healthcare …
diagnostic delay in inflammatory bowel disease-Authors' reply
Letter: diagnostic delay in inflammatory bowel disease-Authors' reply Letter: diagnostic delay in
inflammatory bowel disease-Authors' reply Aliment Pharmacol Ther. 2023 May;57(10):1205-1206 …
inflammatory bowel disease-Authors' reply Aliment Pharmacol Ther. 2023 May;57(10):1205-1206 …
delays to diagnosis of IBD-Challenges requiring a systematic approach. Authors' reply
Letter: delays to diagnosis of IBD-Challenges requiring a systematic approach. Authors' reply
Letter: delays to diagnosis of IBD-Challenges requiring a systematic approach. Authors' reply …
Letter: delays to diagnosis of IBD-Challenges requiring a systematic approach. Authors' reply …